SCHEMBL2914348

SCHEMBL2914348

CCOc1ccc(CC2(C(C(=O)NC3CCCCC3)C3CCCCC3)Nc3ccc(F)cc3N2)cc1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.44
RAB9A P51151 5/20 0.43
NPC1 O15118 4/20 0.43
ALDH1A1 P00352 3/20 0.43
TSHR P16473 1/20 0.43
HSD17B10 Q99714 1/20 0.43
MAPT P10636 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
GAA P10253 1/20 0.40
HPGD P15428 2/20 0.40
HTT P42858 1/20 0.39
TP53 P04637 1/20 0.38
EPHX2 P34913 1/20 0.37
MDM2 Q00987 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2909783 0.92 LMNA (0.46) LMNARAB9ANPC1ALDH1A1TSHR
SCHEMBL2912514 0.86 TP53 (0.40) LMNARAB9ANPC1SMN1; SMN2MEN1
SCHEMBL3649148 0.85 NPC1 (0.42) LMNARAB9ANPC1ALDH1A1TSHR
SCHEMBL3654812 0.85 NPC1 (0.39) LMNARAB9ANPC1TSHRSMN1; SMN2
SCHEMBL3649621 0.84 NPC1 (0.40) RAB9ANPC1MAPTSMN1; SMN2MEN1
SCHEMBL2914853 0.84 MEN1 (0.46) LMNARAB9ANPC1TSHRMEN1
SCHEMBL3644338 0.84 MEN1 (0.44) LMNARAB9ANPC1ALDH1A1TSHR
SCHEMBL3648565 0.84 MAPT (0.44) LMNARAB9ANPC1ALDH1A1TSHR
SCHEMBL2907076 0.83 LMNA (0.47) LMNARAB9ANPC1ALDH1A1TSHR
SCHEMBL3651103 0.82 NPC1 (0.42) LMNARAB9ANPC1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP claimed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO claimed
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP disclosed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO disclosed